Nanomedicine News

RSS

MonoSol, Midatech Announce Positive Study Results of Nano-Based Oral Insulin Formulation

MonoSol Rx, the developer of PharmFilm® drug delivery technology, and Midatech Group Ltd, a global leader and centre of excellence for the design, development, synthesis and manufacture of nanomedicines, today announced positive results from a pre-clinical study of insulin PharmFilm, the first-ever oral insulin film formulation to transbuccally deliver an active therapeutic dose of insulin in a diet-induced diabetic primate model.

5 Jan 2011

New Research Report on Nanotechnology in Drug Delivery

Reportlinker.com announces that a new market research report is available in its catalogue: Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential. Summary GBI R...

5 Jan 2011

MIT Researchers Say That New Scientific Research Model Focuses on Biomedicine

A new model for scientific research known as "convergence" offers the potential for revolutionary advances in biomedicine and other areas of science, according to a white paper issued today by 12 leading MIT researchers.

From Massachusetts Institute of Technology 5 Jan 2011

Scientists Explore Novel Ways to Treat Pancreatic Tumors Using Nanomedicine

A five-year, $16-million grant from the National Cancer Institute will take advantage of specialized expertise developed by scientists at Albert Einstein College of Medicine of Yeshiva University and Montefiore, the Univ...

4 Jan 2011

New Way to Deliver Nano-Based Chemotherapeutic Drugs for Cancer Treatment

University of Arizona researchers may have found a way to deliver chemotherapeutic drugs to cancer tissues in controlled doses without harming healthy body cells.

24 Dec 2010

Particle Sciences Formulates Wax Nanoparticles to Induce Mucosal Response to Antigen

Particle Sciences Inc. (PSI), a leading pharmaceutical CRO has formulated a series of wax nanoparticles that, when coupled with an antigen, enhanced its immunogenicity, increasing both systemic and the mucosal immune res...

23 Dec 2010

Celator Pharmaceuticals' CombiPlex Technology Platform Receives U.S. Patent

Celator Pharmaceuticals today announced the United States Patent and Trademark Office issued U.S Patent No. 7,850,990. This patent adds to the intellectual property surrounding Celator’s innovative technology platforms and products.

22 Dec 2010

NanoViricides to Present Anti-Dengue Drug Candidates Results at Dengue Research Conference

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company") has been invited to present at the meeting “A Re-Emerging Challenge in the Americas: Opportunities for Dengue Research Collaborations” sponsored...

From NanoViricides, Inc 22 Dec 2010

Successful Trial for Gold-Based Nanomedicine for Cancer Treatment

The World Gold Council (WGC) is delighted with the successful phase 1 clinical trial of a unique nanomedicine that uses nanoparticles of gold as the core of a delivery system for tumour targeted drug delivery. The res...

22 Dec 2010

New Market Outlook on Biomarker Industry

Reportlinker.com announces that a new market research report is available in its catalogue: Biomarkers - Technologies, markets and companies. Summary This report follows the broad definition of a biomarker as a cha...

22 Dec 2010